BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

BIO-FD&C Revenue

BIO-FD&C had revenue of 5.36B KRW in the quarter ending June 30, 2026, with 14.55% growth. This brings the company's total for the last twelve months to 19.53B, up 12.64% year-over-year. In the year 2025, BIO-FD&C had annual revenue of 19.18B with 19.37% growth. That makes BIO-FD&C the 35,626th largest company in the world by revenue and 2,272nd in South Korea.

• Revenue (ttm): 19.53B
• Revenue Growth: +12.64%
• P/S Ratio: 3.96
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 74.35B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

• Growth Factor Complex 7.77B 48.3%
• Plant Cell 1.98B 12.3%
• Extract 1.97B 12.3%
• Plant Cell Complex 1.60B 10.0%
• Protein 1.48B 9.2%
• Peptide 941.03M 5.9%
• Complex 86.83M 0.5%
• Other 245.31M 1.5%

By Geography

• South Korea 13.26B 82.5%
• China 1.35B 8.4%
• Other 1.00B 6.2%
• Europe 238.81M 1.5%
• Japan 219.80M 1.4%

Fiscal year ended Dec 31, 2024 See the full BIO-FD&C breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	19.18B	3.11B	19.37%
Dec 31, 2024	16.07B	474.34M	3.04%
Dec 31, 2023	15.59B	-263.23M	-1.66%
Dec 31, 2022	15.86B	3.88B	32.43%
Dec 31, 2021	11.97B	3.33B	38.57%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error